tiprankstipranks
Advertisement
Advertisement

HK:9966 Stock Latest News

Alphamab Oncology Reshapes Company Secretariat, Seeks Listing Rules Waiver
Company AnnouncementsAlphamab Oncology Reshapes Company Secretariat, Seeks Listing Rules Waiver
6d ago
9966
Alphamab’s KN026 Phase III Breast Cancer Trial Hits Key Efficacy Goal
PremiumCompany Announcements
Alphamab’s KN026 Phase III Breast Cancer Trial Hits Key Efficacy Goal
14d ago
9966
Alphamab Oncology Swings to Loss as R&D Spend Climbs but Cancer Pipeline Advances
PremiumCompany Announcements
Alphamab Oncology Swings to Loss as R&D Spend Climbs but Cancer Pipeline Advances
20d ago
9966
Alphamab Starts Phase III Trial of Next-Gen HER2 Drug in High-Risk Breast Cancer
PremiumCompany Announcements
Alphamab Starts Phase III Trial of Next-Gen HER2 Drug in High-Risk Breast Cancer
22d ago
9966
Alphamab Advances JSKN016 Into Phase III for Hard-to-Treat Breast Cancer
PremiumCompany Announcements
Alphamab Advances JSKN016 Into Phase III for Hard-to-Treat Breast Cancer
26d ago
9966
Alphamab Oncology Names New CFO as Capital Markets Vice President Resigns
PremiumCompany AnnouncementsAlphamab Oncology Names New CFO as Capital Markets Vice President Resigns
27d ago
9966
Alphamab Oncology Starts First-in-Human Trial of Novel Bispecific ADC JSKN027
Premium
Company Announcements
Alphamab Oncology Starts First-in-Human Trial of Novel Bispecific ADC JSKN027
29d ago
9966
Alphamab Wins CDE Nod for First-in-Class Dual-Payload Cancer ADC JSKN021
Premium
Company Announcements
Alphamab Wins CDE Nod for First-in-Class Dual-Payload Cancer ADC JSKN021
1M ago
9966
Alphamab Oncology Sets Board Meeting to Approve 2025 Annual Results
PremiumCompany Announcements
Alphamab Oncology Sets Board Meeting to Approve 2025 Annual Results
1M ago
9966
Alphamab Oncology Names Veteran Biologics Executive as Chief Technology Officer
PremiumCompany Announcements
Alphamab Oncology Names Veteran Biologics Executive as Chief Technology Officer
1M ago
9966
Alphamab Oncology’s KN035 NDA for First-Line Biliary Tract Cancer Accepted by China’s NMPA
PremiumCompany Announcements
Alphamab Oncology’s KN035 NDA for First-Line Biliary Tract Cancer Accepted by China’s NMPA
3M ago
9966
Alphamab Wins CDE Acceptance for Phase II Trial of Novel Cervical Cancer Therapy JSKN033
PremiumCompany Announcements
Alphamab Wins CDE Acceptance for Phase II Trial of Novel Cervical Cancer Therapy JSKN033
4M ago
9966
Alphamab Oncology’s JSKN003 Receives FDA Breakthrough Therapy Designation
PremiumCompany AnnouncementsAlphamab Oncology’s JSKN003 Receives FDA Breakthrough Therapy Designation
4M ago
9966
Alphamab Oncology Advances Revolutionary JSKN027 ADC to Clinical Stage
Premium
Company Announcements
Alphamab Oncology Advances Revolutionary JSKN027 ADC to Clinical Stage
4M ago
9966
Alphamab Oncology Initiates HK$30 Million Share Repurchase Plan
Premium
Company Announcements
Alphamab Oncology Initiates HK$30 Million Share Repurchase Plan
5M ago
9966
Alphamab Oncology’s JSKN003 Gains U.S. FDA Fast Track Designation
PremiumCompany Announcements
Alphamab Oncology’s JSKN003 Gains U.S. FDA Fast Track Designation
6M ago
9966
Alphamab Oncology’s JSKN003 Gains U.S. FDA Fast Track Designation
PremiumCompany Announcements
Alphamab Oncology’s JSKN003 Gains U.S. FDA Fast Track Designation
6M ago
9966
Alphamab Oncology Grants Award Shares to Key Personnel
PremiumCompany Announcements
Alphamab Oncology Grants Award Shares to Key Personnel
6M ago
9966
Alphamab Oncology’s JSKN003 Receives Breakthrough Therapy Designation for HER2+ CRC
PremiumCompany Announcements
Alphamab Oncology’s JSKN003 Receives Breakthrough Therapy Designation for HER2+ CRC
6M ago
9966
Alphamab Oncology’s JSKN003 Shows Promising Results in Cancer Treatment Trials
PremiumCompany AnnouncementsAlphamab Oncology’s JSKN003 Shows Promising Results in Cancer Treatment Trials
6M ago
9966
Alphamab Oncology Reports Promising Phase III Trial Results for KN026
Premium
Company Announcements
Alphamab Oncology Reports Promising Phase III Trial Results for KN026
6M ago
9966
Alphamab Oncology Provides Additional Details on 2024 Annual Report
Premium
Company Announcements
Alphamab Oncology Provides Additional Details on 2024 Annual Report
6M ago
9966

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >